Assistant Professor, Internal Medicine, University of Texas Medical School, Houston
Rheumatology
Dr. Shervin Assassi, MD
|
|
Give Review
Shervin Assassi is an expert in the field of Rheumatology. He over the years received 3 awards: "Fellow (FACR)", "Super Doctor" and "Fellow". Shervin Assassi is a published doctor. He published 66 publications, including: 'The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.' He accepts Medicare.
Publications
- Identification of an Association of TNFAIP3 Polymorphisms With Matrix Metalloproteinase Expression in Fibroblasts in an Integrative Study of Systemic Sclerosis-Associa...
- The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.
- Dissecting the Heterogeneity of Skin Gene Expression Patterns in Systemic Sclerosis.
- Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus.
- Antinuclear antibody-negative systemic sclerosis.
- Reply to Inquiry Regarding Ethnicity of Individuals Surveyed in 2009-2010 National Health and Nutrition Examination Survey.
- Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.
- A3.34 The global microrna profile of skin in systemic sclerosis.
- Immunochip analysis identifies multiple susceptibility Loci for systemic sclerosis.
- Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis.
- Identification of cadherin-11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.
- What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis?
- Biopsychosocial typologies of Pain in a cohort of patients with systemic sclerosis.
- Skin gene expression correlates of severity of interstitial lung Disease in systemic sclerosis.
- Can Serum Surfactant Protein D or CC-Chemokine Ligand 18 Predict Outcome of Interstitial Lung Disease in Patients with Early Systemic Sclerosis?
- Measuring illness behavior in patients with systemic sclerosis.
- Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.
- New insight on the Xq28 association with systemic sclerosis.
- Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial.
- C-reactive protein predictsthe long-term progression of interstitial lung Disease and survival in patients with early systemic sclerosis.
- Genetics of scleroderma: implications for personalized medicine?
- Correlation of interferon-inducible chemokine plasma levels with Disease severity in systemic sclerosis.
- Osteopontin in systemic sclerosis and its role in dermal fibrosis.
- IRF5 polymorphism predicts prognosis in patients with systemic sclerosis.
- Lack of Association of the CD247 SNP rs2056626 with Systemic Sclerosis in Han Chinese.
- Autoimmune Disease genetics 2013.
- Association of the HLA-DRB1 with Scleroderma in Chinese Population.
- Right bundle branch block: a predictor of mortality in early systemic sclerosis.
- The Role of Type 1 Interferon in Systemic Sclerosis.
- Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese population.
- Profiling of hla-B alleles for association studies with ankylosing Spondylitis in the chinese population.
- Treatment of early diffuse systemic sclerosis skin Disease.
- A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations.
- Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.
- Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis.
- The contribution of Disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spo...
- Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts.
- Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.
- A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung Disease.
- Cigarette smoking is not a risk factor for systemic sclerosis.
- Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival Analysis.
- Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort.
- HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis.
- Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis.
- Whole-blood gene expression profiling in ankylosing Spondylitis shows upregulation of toll-like receptor 4 and 5.
- Predictors of interstitial lung Disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.
- Association of RNA polymerase III antibodies with scleroderma renal crisis.
- Separate influences of birth order and gravidity/parity on the development of systemic sclerosis.
- Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.
- Autoimmune Diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.
- Psychological correlates of self-reported Disease activity in ankylosing spondylitis.
- Systemic sclerosis and lupus: points in an interferon-mediated continuum.
- Psychological correlates of self-reported functional limitation in patients with ankylosing Spondylitis.
- Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.
- Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis.
- BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians.
- Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.
- Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.
- Clinical and genetic factors predictive of mortality in early systemic sclerosis.
- Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis.
- Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients.
- Clinical, immunologic, and genetic features of familial systemic sclerosis.
- Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
- Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays.
- Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis.
Schools
AlbertLudwigsUniversitaet Freiburg Medizinische Fakultat
University Of Tx
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
Conditions Treated
- Arthritis
- Behçet's Disease
- Bursitis
- Calcium Pyrophosphate Dihydrate Deposition Disease (CPPD)
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- Fellow (FACR)
- Super Doctor
- Fellow
Education
-
University of Texas Health Science Center -
Albert Ludwigs University Faculty of Medicine
Drug Facts
| NPI NUMBER | 1043259567 | |
| NPPES Provider LastName | ASSASSI | |
| NPPES Provider FirstName | SHERVIN | |
| NPPES Provider ZIPCode | 770301501 | |
| NPPES Provider State | TX | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 338.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 20.0 | |
| Percent Opioid Claims | 5.92 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043259567 |
| Last Name Of The Provider | ASSASSI |
| First Name Of The Provider | SHERVIN |
| View All |
Similar Doctors
|
Dr. Padma R. Chimata, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Julie Y. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Courtney J. McCray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Serge De Golovine, MD |
|
|
Dr. Jean H. Tayar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Huifang Lu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luz A. Dhindsa-Castanedo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kiran Farheen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Huma Sohail, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gineth P. Pinto-Patarroyo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John I. Gomez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tareq A. Abou Khamis, MD
This Doctor is OpenDoctor Recommended.
|